Raw Material or API Supply for Naproxen Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract, issued by the Defense Logistics Agency under the Department of Defense, concerns the procurement of active pharmaceutical ingredients or excipients specifically for the formulation of Naproxen Tablets. The primary objective is to secure the necessary raw materials to support manufacturing processes that adhere strictly to current Good Manufacturing Practices and FDA requirements. Classified under NAICS code 325411, the agreement ensures the availability of high-quality components essential for pharmaceutical production. The contract was posted on July 2, 2026, and is managed through the DLA's procurement systems to maintain the supply chain for critical medical supplies.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
This scope was carved out of SPE2DP26F6984.
The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.
NAPROXEN TABLETS
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
